Timber Pharmaceuticals Announces Adjournment of Annual Meeting
Basking Ridge, NJ, June 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc….
Month: June 2021
Evelo Biosciences Announces Inducement Award Plan for Expanding Leadership Team
CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical…
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome
DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq:…
Catalyst Pharmaceuticals, Inc.’s and KYE Pharmaceuticals’ Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi®
– Without an NOC, Ruzurgi® is without a Marketing Authorization in Canada – Matter Remanded…
Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate
Saint-Herblain (France), June 3, 2021 –Valneva SE, a specialty vaccine company focused on the development…
Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study
Men who received 177Lu-PSMA-617 plus best standard of care had a 38% reduction in risk…
Important information about Extraordinary General meeting of shareholders of June 17, 2021
Joint stock company “Olainfarm”, unified registration number 40003007246, legal address: 5 Rūpnīcu Street 5, Olaine,…
Eurobio Scientific launches its COVID antigen self-test
Eurobio Scientific launches its COVID antigen self-test Paris, June 2, 2021 – 5:45 pm Eurobio…
Zynerba Pharmaceuticals Announces Presentation of Efficacy and Safety Findings in Children and Adolescents with Autism Spectrum Disorder (ASD) and Related Disorders at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
DEVON, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Syneos Health Launches Patient Voice Consortium
Consortium Advances Behavioral Insights and Diverse Patient Perspectives Across Product Development Lifecycle MORRISVILLE, N.C., June…
COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
LONDON, June 03, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental…
PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
FLORHAM PARK, N.J., June 03, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Marrone Bio Innovations Partners with ATP Nutrition to Distribute Stargus® Biofungicide in Canada
Agreement Marks Expansion into the Broad Acre Crops Market DAVIS, Calif., June 03, 2021 (GLOBE…
Cue Biopharma to Present at the 2021 Federation of Clinical Immunology Societies (FOCIS) Virtual Annual Meeting
CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
Visionology Acquires Exclusive Worldwide License to SPARCS Contrast Sensitivity Testing Technology
Patented Software to Aid in Identifying Eye Disease and Remotely Monitoring Eye Health NASHVILLE, Tenn.,…
Aeterna Zentaris Announces Final Settlement of Previously Disclosed Class-Action Lawsuit
CHARLESTON, S.C., June 03, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
Resverlogix and EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in the United States and Canada
CALGARY, Alberta and CHICAGO, June 03, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) and EVERSANA™,…
Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects
Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects This year, Sanofi…
Enlivex to Present at the Jefferies 2021 Virtual Healthcare Conference
Nes Ziona, Israel, June 03, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
Avadel to Present New Efficacy and Safety Data from Pivotal Phase 3 REST-ON Trial of FT218 at SLEEP 2021
DUBLIN, Ireland, June 03, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…